Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund
Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.
Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.
ACCC approves DP World Australia’s acquisition of Silk Logistics Holdings Limited (ASX:SLH), ensuring continued competition in the container logistics sector.
Invictus Energy Ltd (ASX:IVZ) announces progress on PPSA and National Project Status for Cabora Bassa Project in Zimbabwe.
Celsius Resources (ASX:CLA) begins engineering for its MCB Copper-Gold Project and extends SODOR’s share return period.
Yowie Group Ltd (ASX:YOW) faces interim orders restraining its takeover bid for Keybridge Capital Limited, impacting the acquisition process.
Noumi Limited (ASX:NOU) secures approval for a $43 million class action settlement, concluding legacy legal issues and enabling focus on business growth.
Delorean Corporation Ltd (ASX:DEL) announces regulatory reforms that enhance its renewable gas projects and biomethane market viability in Australia.
Dexus (ASX:DXS) reports a $55M portfolio valuation increase and announces an 18.0 cents per security distribution for H1 FY25.
PYC Therapeutics (ASX:PYC) aligns with the FDA on registrational trial design for its RP11 treatment, advancing VP-001 to Phase 2/3 studies.
Avenira Limited (ASX:AEV) secures Northern Territory Government approval for Wonarah Phosphate Project, moving towards DSO operations launch in Q4.